Testosterone Replacement Therapy Does Not Increase or Decrease Cardiovascular Risk, Study Finds

Treating men with secondary hypogonadism may not be necessary, but may reduce symptoms and related comorbidities. Endocrinologist Kevin Pantalone, DO, discusses the findings of his latest research, which found that testosterone replacement therapy did not affect cardiovascular risk, and calls for larger studies to evaluate the safety of this therapy.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advertising Policy